COMMON PROCEDURE USED TO TREAT FIBROIDS AND CONDUCT HYSTERECTOMY & MYOMECTOMY IN WOMEN FOUND TO SPREAD CANCER
On April 17, 2014, the United States Food and Drug Administration (the “FDA”) issued a News Release in which it discouraged the use of laparoscopic power power morcellation for the removal of the uterus (i.e., a hysterectomy) or the removal of uterine fibroids (i.e., a myomectomy) in women because, according to the FDA’s research, the treatment can cause the spreading of certain cancers. If a woman that has a type of cancer known as a “uterine sarcoma” undergoes laparoscopic power power morcellation, the FDA has determined that the risk of spreading the cancer throughout the patient’s abdomen and pelvis is significantly elevated, and the chances